The FGFR1 Gene Pfeiffer Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the FGFR1 gene, which are linked to Pfeiffer Syndrome. Pfeiffer Syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones, leading to abnormal shape of the head and face. It may also affect the hands and feet, causing broad, short thumbs and toes. The test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare professionals to devise a tailored treatment and intervention plan for affected individuals. Priced at 4400 AED, this test is a valuable resource for families seeking answers about this complex condition, offering them a clear path towards understanding and managing the syndrome's implications.
The FGFR2 Gene Pfeiffer Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the FGFR2 gene, which are associated with Pfeiffer Syndrome. Pfeiffer Syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones, leading to abnormalities in the shape of the head and face, along with issues related to the hands and feet. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the FGFR2 gene can cause the disorder.
Conducted at DNA Labs UAE, this genetic test is an essential tool for accurate diagnosis, allowing for early intervention and management of the syndrome. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any mutations in the FGFR2 gene that are indicative of Pfeiffer Syndrome.
The cost of the FGFR2 Gene Pfeiffer Syndrome Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the FGFR2 gene. This test is crucial for affected families, providing them with the necessary information for genetic counseling, understanding the risk of recurrence in future pregnancies, and exploring potential treatment options or interventions for managing the symptoms associated with Pfeiffer Syndrome.
The STAC3 Gene Native American Myopathy Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the STAC3 gene, which are associated with Native American Myopathy (NAM). Native American Myopathy is a rare, genetic disorder predominantly found among Native American populations, characterized by muscle weakness, skeletal abnormalities, and potential respiratory and cardiac complications. The condition is inherited in an autosomal recessive manner, meaning that two copies of the mutated gene, one from each parent, are necessary for a child to be affected.
This genetic test is crucial for early diagnosis and management of the condition, enabling healthcare providers to offer targeted treatments and interventions that can significantly improve the quality of life for individuals with NAM. By analyzing a patient's DNA sample, usually obtained through a blood draw, the test specifically looks for the known mutations within the STAC3 gene that are responsible for the disorder.
The cost of the STAC3 Gene Native American Myopathy Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive process of collecting the sample, conducting the genetic analysis, and interpreting the results to provide a conclusive diagnosis. It is a valuable resource for families with a history of the condition or for individuals showing symptoms consistent with Native American Myopathy, offering them a clear understanding of their genetic status and guiding them towards appropriate medical care and support.
The "NALCN Gene Neuroaxonal Neurodegeneration Infantile with Facial Dysmorphism Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the NALCN gene. These mutations are associated with a rare genetic disorder that leads to infantile neuroaxonal neurodegeneration, characterized by progressive neurological deterioration and distinct facial dysmorphism. The test is crucial for early diagnosis, allowing for timely intervention and management of the condition. Priced at 4400 AED, the test involves analyzing the patient's DNA to detect abnormalities in the NALCN gene, providing essential information for healthcare providers to develop an appropriate treatment and support plan for affected individuals and their families.
The "ALK Gene Neuroblastoma Type 3 Susceptibility to Familial Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify genetic predispositions to Type 3 Neuroblastoma associated with mutations in the ALK gene. Neuroblastoma is a type of cancer that most often affects children and is characterized by the development of malignant cancer cells in the adrenal glands or nerve tissue along the spine. The ALK gene plays a crucial role in the development of the nervous system, and mutations in this gene have been linked to an increased risk of developing neuroblastoma.
This genetic test is particularly valuable for families with a history of neuroblastoma, as it can help identify at-risk individuals through the detection of specific genetic markers associated with the condition. Early identification of susceptibility can lead to vigilant monitoring and prompt intervention, potentially improving outcomes for those diagnosed with the disease.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and commitment to providing accurate and actionable results. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive information it provides to patients and their families. By opting for this test, families can gain crucial insights into their genetic makeup, enabling informed decisions regarding health and preventive measures against neuroblastoma.
The SMARCA2 gene Nicolaides-Baraitser Syndrome (NCBRS) genetic test is a specialized diagnostic tool used to identify mutations in the SMARCA2 gene, which are responsible for causing Nicolaides-Baraitser Syndrome. NCBRS is a rare genetic disorder characterized by sparse hair, distinctive facial features, intellectual disability, and other physical anomalies. The genetic test involves analyzing the DNA of the individual to detect specific mutations in the SMARCA2 gene that are linked to the syndrome.
This test is particularly crucial for individuals who show symptoms of NCBRS, as a confirmed genetic diagnosis can help in managing the condition more effectively through targeted interventions and support. It also provides valuable information for family planning and genetic counseling for affected families.
The test is available at DNA Labs UAE, a leading facility specializing in genetic and molecular diagnostics. The cost of the SMARCA2 gene Nicolaides-Baraitser Syndrome genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis needed to accurately identify the presence of SMARCA2 gene mutations, providing peace of mind and a clear path forward for affected individuals and their families.
The NBN Gene Nijmegen Breakage Syndrome Genetic Test is a specialized diagnostic procedure designed to detect mutations in the NBN gene, which are indicative of Nijmegen Breakage Syndrome (NBS). NBS is a rare autosomal recessive genetic disorder characterized by microcephaly, a distinct facial appearance, growth retardation, immunodeficiency, and an increased risk of cancer, particularly lymphoma. The test is crucial for the early identification of the syndrome, allowing for appropriate medical management and surveillance for complications associated with the condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the NBN gene to identify the specific mutations associated with Nijmegen Breakage Syndrome. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to accurately detect and interpret the genetic variations responsible for the syndrome.
By opting for the NBN Gene Nijmegen Breakage Syndrome Genetic Test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic health, enabling informed decisions regarding their medical care and the management of the syndrome's various health implications.
The "SHOC2 Gene Noonan Syndrome-like Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the SHOC2 gene that are associated with a Noonan syndrome-like disorder. This condition shares many characteristics with Noonan syndrome, including distinctive facial features, heart defects, developmental delays, and short stature, but it is caused by specific mutations in the SHOC2 gene. The test involves analyzing the patient's DNA to identify any abnormalities in the SHOC2 gene that might indicate the presence of the syndrome. With a cost of 4400 AED, this genetic test is a valuable resource for families seeking answers to complex genetic questions, offering them a clearer understanding of their genetic health and enabling healthcare providers to tailor more effective treatment and management plans for affected individuals.
The PTPN11 gene Noonan Syndrome Type 1 genetic test is a specialized diagnostic tool used to identify mutations in the PTPN11 gene, which are linked to Noonan Syndrome Type 1. Noonan Syndrome is a genetic disorder that affects various parts of the body and is characterized by distinctive facial features, heart defects, developmental delays, and other physical abnormalities. The PTPN11 gene plays a crucial role in the development and function of many body systems, and mutations in this gene are the most common genetic cause of Noonan Syndrome.
This test is particularly important for individuals who exhibit symptoms of Noonan Syndrome or have a family history of the condition, as it can provide a definitive diagnosis. Early diagnosis is vital for managing the symptoms and improving the quality of life for those affected. The test involves analyzing the DNA to look for specific mutations in the PTPN11 gene that are known to cause Noonan Syndrome.
The PTPN11 gene Noonan Syndrome Type 1 genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable test results. By opting for this test at DNA Labs UAE, individuals can take an important step towards understanding their genetic health and making informed decisions about their care and the care of their families.
The LZTR1 gene Noonan Syndrome Type 10 genetic test is a specialized diagnostic tool used to identify mutations in the LZTR1 gene, which are associated with Noonan Syndrome Type 10. Noonan Syndrome is a genetic disorder that affects various parts of the body and is characterized by distinctive facial features, heart defects, developmental delays, and other physical abnormalities. The LZTR1 gene plays a crucial role in the development and function of several body systems, and mutations in this gene can lead to the symptoms associated with Noonan Syndrome Type 10.
Conducted at DNA Labs UAE, this test is designed to provide individuals and families with critical genetic information that can aid in the diagnosis, management, and understanding of Noonan Syndrome Type 10. By analyzing a sample of the patient's DNA, the test identifies specific genetic alterations in the LZTR1 gene that are linked to the condition.
The cost of the LZTR1 gene Noonan Syndrome Type 10 genetic test is 4400 AED. This price includes the genetic analysis and a comprehensive report that explains the test results. The report is an essential resource for healthcare providers to develop an appropriate care plan and for patients and families to understand the genetic basis of the condition, potential health implications, and the risk of passing the mutation to future generations.
DNA Labs UAE is equipped with advanced genetic testing technology and staffed by experienced professionals who ensure the accuracy and confidentiality of the test results. The facility provides a supportive environment for individuals undergoing genetic testing, offering guidance and resources to help them navigate the complexities of genetic conditions like Noonan Syndrome Type 10.
